SST-tTA2-D knock-in/knock-out mice have synthetic modified tetracycline-regulated transactivator (tTA2S) gene expression directed to Sst-expressing cells by the endogenous promoter/enhancer elements of the somatostatin locus. These SST-tTA2-D mice are a Tet-Off tool that allows dox-conditional expression of genes in Sst-expressing cells/tissues.
Hongkui Zeng, Allen Institute for Brain Science
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Transactivator) | Sst | somatostatin |
The SST-tTA2-D (SST-tTA2-Δ) knock-in/knock-out allele both abolishes Sst gene function and expresses a synthetic modified tetracycline-regulated transactivator (tTA2S) from the somatostatin promoter/enhancer elements.
Heterozygous mice are viable and fertile. Although the donating investigator did not evaluate the phenotype of homozygous animals to date (October 2011), homozygous mice may be expected to have a knockout phenotype similar to other null mutations of this gene and may exhibit nervous system and metabolic abnormalities.
When SST-tTA2-D mice are bred with mice carrying a gene of interest under the regulatory control of a tetracycline-responsive promoter element (TRE, TetRE or tetO), expression of the target gene in the somatostatin-expressing cells may be conditionally abolished with administration of the tetracycline analog doxycycline (dox) in the double mutant offspring. Specifically, the donating investigator reports that SST-tTA2-D activates tetO-regulated gene expression in scattered neural populations, in a pattern that resembles Sst expression. The donating investigator did not examine tTA2S activity in tissues other than brain.
A targeting vector was used to insert a synthetic modified tetracycline-regulated transactivator (tTA2S) gene and 3' UTR region of the somatostatin exon 2 into the ATG transcriptional start site of the somatostatin gene (Sst). Specifically, the targeting vector was designed with (from 5' to 3') an frt3 site, a Cre recombinase gene, a bovine growth hormone polyA sequence, a second frt3 site, a tTA2S gene, the 3' UTR region from somatostatin exon 2, an AttB site, PGK-Neo-polyA cassette, an frt5 site, an RNA splice acceptor, the 3' portion of the hygromycin gene with SV40 polyA signal, and an AttP site. This construct was electroporated into (129S6/SvEvTac x C57BL/6)F1-derived G4 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts, and chimeric animals were bred to C57BL/6J mice to generate the SST-Cre-pA-tTA2 mutant colony. To remove the frt-flanked Cre recombinase and polyA sequence, the mice were bred to ROSA26::FLPe deleter mice (129S4 genetic background; Stock No. 003946). The SST-tTA2 offspring were then bred to PhiC31-expressing mice (C57BL/6J congenic background; see Stock No. 007743) to replace the PGK-Neo and hygromycin-polyA cassettes with the recombined AttB/AttP site (AttL). The resulting SST-tTA2-D (or SST-tTA2-Δ) mice have a single frt3 site, tTA2S, the 3' UTR from somatostatin exon 2, and AttL site targeted into the somatostatin ATG site. The SST-tTA2-Δ mice were subsequently backcrossed to C57BL/6J wildtype mice for at least five additional generations (and the FLP-expressing mutation and PhiC31 transgene was removed) prior to sending to The Jackson Laboratory Repository. Upon arrival, mice were bred with C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the living colony.
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
---|---|
Site of Expression | Ssttm1.2(tTA2)Hze activates tetO-regulated gene expression in scattered neural populations, in a pattern that resembles Sst expression. |
Allele Name | targeted mutation 1.2, Hongkui Zeng |
---|---|
Allele Type | Targeted (Transactivator) |
Allele Synonym(s) | SST-tTA2-D; SST-tTA2-DELTA; SST-tTA2-deltaNEO |
Gene Symbol and Name | Sst, somatostatin |
Gene Synonym(s) | |
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
Site of Expression | Ssttm1.2(tTA2)Hze activates tetO-regulated gene expression in scattered neural populations, in a pattern that resembles Sst expression. |
Strain of Origin | (129S6/SvEvTac x C57BL/6NCrl)F1 |
Chromosome | 16 |
Molecular Note | A targeting vector used to insert a synthetic modified tetracycline-regulated transactivator (tTA2S) gene and 3' UTR region of the somatostatin exon 2 into the ATG transcriptional start site of the somatostatin gene (Sst). Specifically, the targeting vector was designed with (from 5' to 3') an frt3 site, a Cre recombinase gene, a bovine growth hormone polyA sequence, a second frt3 site, a tTA2S gene, the 3' UTR region from somatostatin exon 2, an AttB site, PGK-Neo-polyA cassette, an frt5 site, an RNA splice acceptor, the 3' portion of the hygromycin gene with SV40 polyA signal, and an AttP site. |
Mutations Made By | Hongkui Zeng, Allen Institute for Brain Science |
When maintaining a live colony, heterozygous mice may be bred to wildtype siblings from the colony or to C57BL/6J inbred mice (Stock No. 000664). The homozygous phenotype is unknown (September 2011).
When using the SST-tTA2-D mouse strain in a publication, please cite the originating article(s) and include JAX stock #016868 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Sst<tm1.2(tTA2)Hze> |
Frozen Mouse Embryo | B6.Cg-Sst<tm1.2(tTA2)Hze>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Sst<tm1.2(tTA2)Hze>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Sst<tm1.2(tTA2)Hze>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Sst<tm1.2(tTA2)Hze>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.